We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MNOV market cap is 65.23M. The company's latest EPS is USD -0.1748 and P/E is -7.84.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 1M | 0 |
| Operating Income | -3.23M | -2.96M | -3.3M | -1.15M | -2.49M |
| Net Income | -3M | -2.92M | -2.87M | -723k | -2.06M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 4.04M | 0 | 1M |
| Operating Income | -14.03M | -14.18M | -10.22M | -14.63M | -9.9M |
| Net Income | -12.94M | -13.85M | -10.13M | -14.07M | -8.57M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 74.16M | 71.13M | 68.72M | 68.14M | 66.27M |
| Total Liabilities | 3.91M | 3.41M | 3.54M | 3.47M | 3.89M |
| Total Equity | 70.24M | 67.73M | 65.18M | 64.67M | 62.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 79.21M | 75.42M | 87.41M | 74.16M | 66.27M |
| Total Liabilities | 4.31M | 4.09M | 3.73M | 3.91M | 3.89M |
| Total Equity | 74.9M | 71.33M | 83.68M | 70.24M | 62.38M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.91M | -3.18M | -5.56M | -6.93M | -7.43M |
| Investing | -40.01M | 39.93M | 39.91M | 39.91M | 39.91M |
| Financing | 8k | N/A | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.13M | -10.83M | -9.38M | -12.91M | -7.43M |
| Investing | -11k | -36k | -29k | -40.01M | 39.91M |
| Financing | 10.62M | 7.11M | 20.78M | 8k | N/A |
| Market Cap | 65.23M |
| Price to Earnings Ratio | -7.84 |
| Price to Sales Ratio | 67.16 |
| Price to Cash Ratio | 1.32 |
| Price to Book Ratio | 1.08 |
| Dividend Yield | - |
| Shares Outstanding | 49.05M |
| Average Volume (1 week) | 25.18k |
| Average Volume (1 Month) | 20.83k |
| 52 Week Change | -40.63% |
| 52 Week High | 2.66 |
| 52 Week Low | 1.26 |
| Spread (Intraday) | 1.47 (52.5%) |
| Company Name | Medicinova Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.medicinova.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
